missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Clozapine N-oxide
Description
Metabolite of clozapine (Cat. No. 0444). Activates human muscarinic designer receptors (DREADDs) in vitro. Silences hippocampal neurons expressing hM4 DREADDs in vitro. Activates Gs-linked DREADDS- AgRP in mice via intracerebroventricular (i.c.v) injection. Shown to be a P-glycoprotein (P-gp) efflux pump substrate. Other potent and selective hM3Dq DREADD agonists available: DREADD agonist 21 and Perlapine .
Water soluble salt also available.
This product contains 1 molar equivalent of ethanol.
Spécifications
Spécifications
| Assay Percent Range | >98% |
| Quantity | 10 mg |
| Formula Weight | 342.82 |
| Purity | >99% |
| Molecular Weight (g/mol) | 342.827 |
| Chemical Name or Material | Clozapine N-oxide |
Sécurité et manipulation
| Recommended Storage | Store at Room Temperature |